In parallel, ACSL1 has been previously reported to be down-regulated in non-small cell lung cancer (NSCLC) and liver cancer, with its tumor-suppressive effects in NSCLC having been demonstrated by Chen, W.C et al. [19, 20]. The gene discussed is ACSL1; the disease is neoplasm.